Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Aspects of Anthracycline Cardiotoxicity
Michele Russo, Angela Della Sala, Carlo G. Tocchetti, et al.
Current Treatment Options in Oncology (2021) Vol. 22, Iss. 2
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Drug-induced oxidative stress in cancer treatments: Angel or devil?
Hao Jiang, Jing Zuo, Bowen Li, et al.
Redox Biology (2023) Vol. 63, pp. 102754-102754
Open Access | Times Cited: 92
The cardioprotective effects of nano‐curcumin against doxorubicin‐induced cardiotoxicity: A systematic review
Hossein Moutabian, Ruhollah Ghahramani‐Asl, Tohid Mortezazadeh, et al.
BioFactors (2022) Vol. 48, Iss. 3, pp. 597-610
Closed Access | Times Cited: 57
Doxorubicin-induced cardiotoxicity: causative factors and possible interventions
Isobel C Jones, Crispin R. Dass
Journal of Pharmacy and Pharmacology (2022) Vol. 74, Iss. 12, pp. 1677-1688
Closed Access | Times Cited: 46
Anthracycline Cardiotoxicity in Adult Cancer Patients
Massimiliano Camilli, Carlo M. Cipolla, Susan Dent, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 5, pp. 655-677
Open Access | Times Cited: 11
A Comprehensive Review of Cancer Drug–Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies
Vincenzo Costanzo, Yashwant Kumar Ratre, Emanuela Andretta, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 4, pp. 465-495
Closed Access | Times Cited: 8
An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity
Sicong Xie, Yuwei Sun, Xuan Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
In Vitro and In Vivo Cardioprotective Effects of Curcumin against Doxorubicin-Induced Cardiotoxicity: A Systematic Review
Qian Zhang, Lei Wu
Journal of Oncology (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 27
Anthracycline-induced cardiotoxicity: mechanisms, monitoring, and prevention
Yun Qiu, Piao Jiang, Yingmei Huang
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 20
COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis
Peipei Zhang, Hao Lu, Yuanyuan Wu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10400-10400
Open Access | Times Cited: 16
Sodium-glucose cotransporter-2 inhibitors improve clinical outcomes in patients with type 2 diabetes mellitus undergoing anthracycline-containing chemotherapy: an emulated target trial using nationwide cohort data in South Korea
Hui‐Jeong Hwang, Minji Kim, Ji Eun Jun, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
The pathogenesis and therapeutic strategies of heat stroke-induced myocardial injury
Rui Xia, Meng Sun, Yuling Li, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
Exercise training partly ameliorates cardiac dysfunction in mice during doxorubicin treatment of breast cancer
Tytti‐Maria Uurasmaa, Pauline Bourdin, Wail Nammas, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Signal amplification of low concentration doxorubicin detection using the impact electrochemistry of Cu-Co bimetallic nanoparticles with CN vacancies
Haosen Xiong, Shihan Zhang, Wensheng Liao, et al.
Microchemical Journal (2025), pp. 112854-112854
Closed Access
Doxorubicin-induced cardiometabolic disturbances: what can we do?
Ashot Avagimyan, Nana Pogosova, Manfredi Rizzo, et al.
Frontiers in Clinical Diabetes and Healthcare (2025) Vol. 6
Open Access
Genetic Background in Patients with Cancer Therapy-Induced Cardiomyopathy
Luca Fazzini, N Campana, Stefano Cossu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1286-1286
Open Access
The role of iron in doxorubicin-induced cardiotoxicity: recent advances and implication for drug delivery
Yan Qin, Tao Guo, Zheng Wang, et al.
Journal of Materials Chemistry B (2021) Vol. 9, Iss. 24, pp. 4793-4803
Closed Access | Times Cited: 38
Novel Mechanisms of Anthracycline-Induced Cardiovascular Toxicity: A Focus on Thrombosis, Cardiac Atrophy, and Programmed Cell Death
Silvio Antoniak, Sukanya Phungphong, Zhaokang Cheng, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 26
Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart Tissues
Annet N. Linders, Itamar Braga Dias, Ekaterina S. Ovchinnikova, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 3, pp. 298-315
Open Access | Times Cited: 14
Natural Products for Preventing and Managing Anthracycline-Induced Cardiotoxicity: A Comprehensive Review
Jarosław Szponar, Przemysław Niziński, Jarosław Dudka, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1151-1151
Open Access | Times Cited: 4
Cancer Therapy-Induced Cardiotoxicity—A Metabolic Perspective on Pathogenesis, Diagnosis and Therapy
Anurag Choksey, Kerstin N. Timm
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 441-441
Open Access | Times Cited: 31
Multimodality Advanced Cardiovascular and Molecular Imaging for Early Detection and Monitoring of Cancer Therapy-Associated Cardiotoxicity and the Role of Artificial Intelligence and Big Data
Jennifer M. Kwan, Evangelos K. Oikonomou, Mariana L. Henry, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 21
Relevance of Ferroptosis to Cardiotoxicity Caused by Anthracyclines: Mechanisms to Target Treatments
Guoxia Zhang, Chao Yuan, Xin Su, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 21
The Beneficial Role of Physical Exercise on Anthracyclines Induced Cardiotoxicity in Breast Cancer Patients
Eliana Tranchita, Arianna Murri, Elisa Grazioli, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2288-2288
Open Access | Times Cited: 18
The Role of Mitochondrial Quality Control in Anthracycline-Induced Cardiotoxicity: From Bench to Bedside
Yukun Li, Rong Lin, Xiaodong Peng, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 17
The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity
Jiazheng Zhao, Ning Zhang, Xiaowei Ma, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top